NCT02992015View on ClinicalTrials.gov

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

March 6, 2024

Conditions
Diffuse Intrinsic Pontine Glioma
Interventions
DRUG

Gemcitabine

Participants receive a one time IV dose of gemcitabine prior to having standard of care surgery.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

Children's Hospital Colorado

OTHER

lead

University of Colorado, Denver

OTHER

NCT02992015 - Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma | Biotech Hunter | Biotech Hunter